Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galbusera, M.
Right arrow Articles by Remuzzi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galbusera, M.
Right arrow Articles by Remuzzi, G.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 94 No. 2 (July 15), 1999: pp. 610-620

Increased Fragmentation of von Willebrand Factor, Due to Abnormal Cleavage of the Subunit, Parallels Disease Activity in Recurrent Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura and Discloses Predisposition in Families

Miriam Galbusera, Marina Noris, Chiara Rossi, Silvia Orisio, Jessica Caprioli, Zaverio M. Ruggeri, Barbara Amadei, Piero Ruggenenti, Beatrice Vasile, Giorgio Casari, and Giuseppe Remuzzi on behalf of the Italian Registry of Familial and Recurrent HUS/TTP

From the Clinical Research Center for Rare Diseases "Aldo and Cele Daccò," Mario Negri Institute, Villa Camozzi-Ranica, Italy; The Scripps Research Institute, La Jolla, CA; TIGEM-S. Raffaele Science Park, Milan, Italy; and the Unit of Nephrology and Dialysis, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy.

We investigated here the changes in von Willebrand factor (vWF) multimers in recurrent, sporadic and familial forms of hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP) to see whether they are actually proteolyzed in vivo in these patients. Molecular determinants of fragments in vWF were also characterized to identify possible sites of cleavage of the subunit. Unusually large vWF multimers were found in blood of 8 of 10 patients with recurrent HUS/TTP, both in the acute phase and in remission, but never in familial and sporadic cases. Instead, all of the groups showed evidence of enhanced fragmentation of vWF multimers during the acute phase. Increased fragmentation was also shown by decrease in native 225-kD vWF subunit. In recurrent and sporadic HUS/TTP, enhanced fragmentation normalized at remission, but the abnormality persisted in familial HUS/TTP patients. The latter findings suggest that patients with familial HUS/TTP may have a congenital abnormality in vWF processing. Analysis with specific monoclonal antibodies showed the presence of the normal vWF fragments with apparent molecular mass of 189, 176, and 140 kD in all patients; however, in 6 recurrent and in 5 familial cases, novel fragments that differed in size from normal ones were found. The size of these abnormal fragments differed from one patient to another and none of them was ever found in normal plasma. These results documented, for the first time in HUS/TTP, an abnormal cleavage of the vWF subunit that might account for the increased fragmentation observed in these patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
T. J. Raife, W. Cao, B. S. Atkinson, B. Bedell, R. R. Montgomery, S. R. Lentz, G. F. Johnson, and X. L. Zheng
Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site
Blood, August 20, 2009; 114(8): 1666 - 1674.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H.-M. Tsai, B. Lammle, V. Bianchi, L. Alberio, M. Furlan, G. Remuzzi, M. Galbusera, and P. M. Mannucci
Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura
Blood, November 15, 2002; 100(10): 3839 - 3842.
[Full Text] [PDF]


Home page
BloodHome page
G. Remuzzi, M. Galbusera, M. Noris, M. T. Canciani, E. Daina, E. Bresin, S. Contaretti, J. Caprioli, S. Gamba, P. Ruggenenti, et al.
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
Blood, July 18, 2002; 100(3): 778 - 785.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
J. N. George, J. E. Sadler, and B. Lammle
Platelets: Thrombotic Thrombocytopenic Purpura
Hematology, January 1, 2002; 2002(1): 315 - 334.
[Abstract] [Full Text]


Home page
BloodHome page
A. Veyradier, B. Obert, A. Houllier, D. Meyer, and J.-P. Girma
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases
Blood, September 15, 2001; 98(6): 1765 - 1772.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. N. George
How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
Blood, August 15, 2000; 96(4): 1223 - 1229.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020